ACE2, the vital entry receptor for SARS‐CoV‐2, is overexpressed in certain tumors such as colon adenocarcinoma, renal carcinomas, pancreatic adenocarcinoma, and lung adenocarcinoma, potentially increasing viral susceptibility. Here, ACE2 is linked to renal carcinoma.